Parthenon LLC’s Eli Lilly LLY Stock Holding History

Parthenon LLC’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.71M	Sell	3,923 -160	-4%	-$163K	0.49%	42
2026 Q1	$3.76M	Sell	4,083 -173	-4%	-$175K	0.43%	46
2025 Q4	$4.57M	Sell	4,256 -46	-1%	-$44K	0.49%	42
2025 Q3	$3.28M	Sell	4,302 -790	-16%	-$588K	0.36%	49
2025 Q2	$3.97M	Buy	5,092 +50	+1%	+$38.9K	0.45%	47
2025 Q1	$4.16M	Sell	5,042 -310	-6%	-$258K	0.51%	44
2024 Q4	$4.13M	Sell	5,352 -315	-6%	-$261K	0.5%	40
2024 Q3	$5.02M	Hold	5,667	–	–	0.6%	38
2024 Q2	$5.13M	Hold	5,667	–	–	0.65%	35
2024 Q1	$4.41M	Sell	5,667 -98	-2%	-$69.7K	0.56%	39
2023 Q4	$3.36M	Buy	5,765 +98	+2%	+$57.2K	0.46%	43
2023 Q3	$3.04M	Hold	5,667	–	–	0.46%	45
2023 Q2	$2.66M	Hold	5,667	–	–	0.38%	49
2023 Q1	$1.95M	Sell	5,667 -259	-4%	-$87.3K	0.3%	55
2022 Q4	$2.17M	Hold	5,926	–	–	0.36%	53
2022 Q3	$1.92M	Hold	5,926	–	–	0.35%	53
2022 Q2	$1.92M	Sell	5,926 -36	-0.6%	-$10.8K	0.33%	52
2022 Q1	$1.71M	Hold	5,962	–	–	0.25%	60
2021 Q4	$1.65M	Hold	5,962	–	–	0.23%	63
2021 Q3	$1.38M	Hold	5,962	–	–	0.21%	65
2021 Q2	$1.37M	Hold	5,962	–	–	0.21%	66
2021 Q1	$1.11M	Buy	5,962 +149	+3%	+$29.1K	0.18%	67
2020 Q4	$981K	Buy	5,813 +151	+3%	+$22.5K	0.17%	73
2020 Q3	$838K	Hold	5,662	–	–	0.16%	69
2020 Q2	$930K	Hold	5,662	–	–	0.19%	67
2020 Q1	$785K	Hold	5,662	–	–	0.19%	67
2019 Q4	$744K	Sell	5,662 -216	-4%	-$25K	0.15%	72
2019 Q3	$657K	Sell	5,878 -130	-2%	-$14.5K	0.14%	73
2019 Q2	$666K	Hold	6,008	–	–	0.14%	73
2019 Q1	$780K	Sell	6,008 -945	-14%	-$115K	0.17%	68
2018 Q4	$805K	Hold	6,953	–	–	0.2%	67
2018 Q3	$746K	Sell	6,953 -2,106	-23%	-$211K	0.16%	74
2018 Q2	$773K	Hold	9,059	–	–	0.18%	75
2018 Q1	$701K	Hold	9,059	–	–	0.17%	73
2017 Q4	$765K	Sell	9,059 -120	-1%	-$10.2K	0.17%	75
2017 Q3	$785K	Hold	9,179	–	–	0.19%	72
2017 Q2	$755K	Hold	9,179	–	–	0.18%	74
2017 Q1	$772K	Hold	9,179	–	–	0.18%	74
2016 Q4	$675K	Buy	9,179 +120	+1%	+$8.94K	0.17%	77
2016 Q3	$727K	Hold	9,059	–	–	0.18%	71
2016 Q2	$713K	Sell	9,059 -505	-5%	-$38K	0.18%	73
2016 Q1	$689K	Hold	9,564	–	–	0.18%	72
2015 Q4	$806K	Hold	9,564	–	–	0.21%	69
2015 Q3	$800K	Sell	9,564 -420	-4%	-$35.5K	0.22%	66
2015 Q2	$834K	Sell	9,984 -100	-1%	-$7.62K	0.22%	66
2015 Q1	$733K	Buy	10,084 +270	+3%	+$19.2K	0.19%	70
2014 Q4	$677K	Buy	9,814 +150	+2%	+$10.1K	0.19%	66
2014 Q3	$627K	Hold	9,664	–	–	0.18%	66
2014 Q2	$601K	Hold	9,664	–	–	0.18%	65
2014 Q1	$569K	Hold	9,664	–	–	0.17%	67
2013 Q4	$493K	Sell	9,664 -400	-4%	-$20K	0.15%	66
2013 Q3	$507K	Buy	10,064 +500	+5%	+$26.2K	0.17%	64
2013 Q2	$470K	Buy	+9,564	New	+$520K	0.16%	62

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Parthenon LLC's LLY Position: Q2 2026 in Review

Parthenon LLC reduced its Eli Lilly (LLY) stake by 3.9% in Q2 2026, selling an estimated $163K and leaving 3,923 shares worth $4.71M. The position accounts for 0.49% of the portfolio, ranked #42.

Parthenon LLC first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.13M in Q2 2024. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Parthenon LLC held 3,923 shares of Eli Lilly worth $4.71M as of Q2 2026.
Parthenon LLC sold 160 Eli Lilly shares in Q2 2026, an estimated $163K.
Eli Lilly made up 0.49% of Parthenon LLC's portfolio in Q2 2026, its #42 holding.
Parthenon LLC first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
Parthenon LLC's Eli Lilly position peaked at $5.13M in Q2 2024.
2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Parthenon LLC's 13F filing for Q2 2026, filed 23 Jul 2026.